61 results on '"K. M., Jagathnath Krishna"'
Search Results
2. Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
- Author
-
Varghese, Bipin T., Nadarajan, Abinaya R., Thomas, Shaji, Iype, Elizabeth Mathew, George, Nebu Abraham, K. M., Jagathnath Krishna, Lal, Sahya S., and Somanathan, Thara
- Published
- 2023
- Full Text
- View/download PDF
3. Outcomes and Prognostic Factors of Extensive Stage Small Cell Lung Cancer: A Retrospective Study
- Author
-
Veena PS, Sajeed A., Geethi MH, K. M. Jagathnath Krishna, Sivananadan CD, Arun Sankar S., Roshni S., and Lijeesh AL
- Subjects
outcome ,pci ,prognostic factors ,small cell lung cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Veena PS Introduction Small cell lung cancer (SCLC) represents about 15% of all lung cancers. Extensive stage (ES) SCLC represents around 60% of diagnosed SCLC cancers. The median survival in untreated ES SCLC is 2 to 4 months and that of treated cases is 8 to 13 months. Aim and Objectives This retrospective analysis aims to find out the clinical outcome of patients with ES SCLC and the prognostic factors affecting their survival. Methods Details of patients registered in the department of radiation oncology from January 1, 2010 to September 30, 2019 were retrieved from the hospital records. This includes the demographic characteristics, treatment received, toxicity, and follow-up details. Results Two-hundred eighty-three patients were included. Median age of presentation was 62 years. Around 97.5% of patients were men. Smokers constitute 94% of all cases. About 86.9% (246 patients) of cases were not alive at the end of the study period. The median estimated overall survival (OS) was 7 months ± 0.47 (95% confidence interval [CI]: 6.026–7.974) and progression-free survival (PFS) was 5 months ± 0.535 (95% CI: 3.952–6.048). Multivariate analysis showed that Eastern Cooperative Oncology Group performance status (ECOG PS), hyponatremia, number of chemotherapy cycles, consolidative radiotherapy (RT) and prophylactic cranial irradiation (PCI) were found to have prognostic effect on OS. Smoking, ECOG PS, number of chemotherapy cycles, consolidative RT, and PCI were found to have prognostic effects on PFS. Conclusion There is a difference in OS and PFS patterns of ES SCLC patients among various Indian studies even though the available data is scarce. Our study shows that the OS and PFS of our study population are comparable to other South Indian studies available. PS, serum sodium level, number of chemotherapy cycles, consolidative RT, and PCI were found to be independent prognostic factors for survival of ES SCLC. The identification of these factors will help physicians to tailor treatment.
- Published
- 2023
- Full Text
- View/download PDF
4. Preoperative incremental shuttle walk test for morbidity and mortality prediction in elective major colorectal surgery
- Author
-
C N Soumya, Mary Thomas, Subha Ravindran, and K M Jagathnath Krishna
- Subjects
colorectal surgery ,morbidity ,postoperative complication ,preoperative care ,walk test ,Anesthesiology ,RD78.3-87.3 - Abstract
Background and Aims: The incremental shuttle walk test (ISWT) is a simple reproducible and non-invasive test for assessing cardiopulmonary function. The maximum oxygen consumption is less than 10 ml/kg/min for ISWT distance of less than 250 m. This study aimed to evaluate the effectiveness of ISWT in predicting morbidity and mortality in elective colorectal oncosurgery and to find the correlation of ISWT with the Duke Activity Status Index (DASI), Borg dyspnoea score, and peak oxygen uptake (VO2 max). Methods: This prospective study involved 46 patients aged more than 60 years with American Society of Anesthesiologists physical status I and II undergoing elective colorectal surgery under general anaesthesia with an epidural block. ISWT was conducted preoperatively and patients were monitored for 30 days postoperatively. For a comparative analysis, patients were divided into two groups: group 1– who could walk 250 m and group 2 – could not walk 250m. Categorical data were evaluated using the Chi-square test, while continuous data were evaluated using the Student's t-test. The strength of correlation was determined using Pearson's correlation coefficient. Results: Postoperative complications (P = 0.001) and lengthy stay in hospital and intensive care unit (P = 0.001) were experienced by all patients who were unable to complete the ISWT distance of 250 m. ISWT distance of 250 m corresponds to a DASI score of 10.5, which is equivalent to a calculated VO2 max of 14.1ml/kg/min. Conclusion: The ISWT with a cutoff distance of 250 m is a reliable predictor of postoperative morbidity in patients undergoing colorectal oncosurgery.
- Published
- 2022
- Full Text
- View/download PDF
5. Clinico pathological characteristics and survival outcome in oral cavity cancer with masticator space involvement (T4b) - A single institutional experience
- Author
-
Nebu Abraham George, K P Abdulla, K M Jagathnath Krishna, Reshma, Malu Rafi, Shaji Thomas, Bipin T Varghese, and Elizabeth Mathew Iype
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Introduction: Oral cavity cancer with the masticator space involvement is considered as very advanced localised diseas e and staged as T4b in AJCC 8th edition. NCCN guidelines consider this as inoperable. This study intends to compare the different treatment modalities in T4b oral cavity cancer and their impact on survival. Patients and methods: This is a retrospective study of 150 patients with T4b oral cavity ca, from 2013to 2015 and follow up data till 31 st July 2019 were collected. All patients had biopsy proven SCC and CT evidence of masticator space involvement. Results: Total of 150 patients were included. 102 patients had received curative treatment and 48 patients had received palliative treatment. In the curative group 84% were treated with surgery and adjuvant treatment and remaining had received RT with or without chemotherapy. 90% patients in the surgically treated group had attained margin negative resection. 4 year OS in the curatively treated group was 58.9% and in the palliative group was 12%. The surgically treated patients in the curative arm had a significant survival advantage over the patients who had received only RT with or without chemotherapy, (63.5% v/s 34%, p = 0.001). Conclusion: Curatively treated oral cavity cancer with masticator space involvement has survival outcome comparable to the published survival data of those without masticator space involvement. Radical intent treatment, preferably surgery should be offered to all patients with masticator space involvement, if negative margin is anticipated from preoperative imaging
- Published
- 2023
- Full Text
- View/download PDF
6. Effect of BIS monitoring on sevoflurane consumption in patients undergoing breast cancer surgeries under general anesthesia—a prospective observational study
- Author
-
Archana Nair, Sudha Padmam, Subha Ravindran, Rachel Cherian Koshy, and K. M. Jagathnath Krishna
- Subjects
Bispectral index ,Sevoflurane consumption ,Breast cancer surgery ,Anesthesiology ,RD78.3-87.3 ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Abstract Background The bispectoral index (BIS), a parameter derived from electroencephalogram, has been used to assess the depth of anesthesia. The objectives of this study were to evaluate the effect of BIS monitoring on sevoflurane consumption and recovery profile at the end of anesthesia. After obtaining Institutional Review Board approval and written informed consent, 25 American Society of Anesthesiologists (ASA) physical status classification 1 and 2 patients undergoing breast cancer surgeries who had BIS monitoring in addition to standard ASA monitoring (BIS GROUP) were compared against 25 controls (control group). In the control group, adequate depth of anesthesia was maintained using routine clinical parameters like heart rate (HR), mean arterial pressure (MAP), and minimum alveolar concentration (MAC) of sevoflurane, while in the BIS group, it was maintained by keeping the BIS score between 40 and 60 (mean 50). Data including demographics, sevoflurane consumption, hemodynamic variables, and recovery profile at the end of anesthesia was assessed in terms of time for eye opening (TEO), time for motor response (TMR), time for extubation (TE), and modified Aldrete scoring (MAS). Results The mean sevoflurane consumption was lower (P = 0.019) in the BIS group. TEO (P = 0.001), TMR (P = 0.0001), and TE (0.003) were shorter in the BIS group. Difference in MAS between the 2 groups was not statistically significant (P = 0.085). Conclusions BIS monitoring during anesthesia resulted in significant reduction in the sevoflurane consumption. Patients who had BIS monitoring awoke earlier and had better recovery profile at the end of anesthesia.
- Published
- 2021
- Full Text
- View/download PDF
7. Performance in 6-min walk test in prediction of post-operative pulmonary complication in major oncosurgeries: A prospective observational study
- Author
-
Sethu Lekshmi Sathyaprasad, Mary Thomas, Frenny Ann Philip, and K M Jagathnath Krishna
- Subjects
exercise test ,oncosurgery ,perioperative care ,post-operative complications ,prospective studies ,walk test ,Anesthesiology ,RD78.3-87.3 - Abstract
Background and Aims: Post-operative pulmonary complications (PPC) contribute to increased morbidity and mortality, necessitating pre-operative functional assessment. Six-minute walk test (6MWT) is a simple option for functional assessment. Methods: This is a prospective observational study conducted in 75 patients who underwent elective abdominal or thoracic oncosurgery under general anaesthesia with either age above 60 years or with cardiopulmonary diseases or obstructive sleep apnoea or low serum albumin or smoking. Patients with history of acute coronary syndrome in past 6 months, dyspnoea at rest, severe pain, inability to walk or interpret instructions and haemodynamic instability were excluded. Preoperatively 6MWT was conducted according to the American Thoracic Society guidelines and patients were observed for PPC. Patients were divided into two groups: group 1–no PPC and group 2–developed PPC. Statistical analysis was done using SPSS software (version 11.0.1). Categorical variables were assessed using Chi-square/Fisher's exact test and continuous variables using student's t-test/Mann-Whitney U test. Association was tested using logistic regression. Results: Out of the 75 patients, 40 patients had no PPC (group 1) and 35 patients had PPC (group 2) including a death. The 6MWD of group with PPCs was significantly less (344 ± 61.927 m) compared to the group without PPCs (442.28 ± 83.194 m, P value = 0.001). The cut-off 6MWD obtained was 390 m, which correlated with longer duration of hospital stay and ICU stay (P = 0.001). Conclusion: Six-minute walk test is a reliable predictor of post-operative pulmonary complications with a cut-off 6MWD of 390 m in the studied oncosurgery patients.
- Published
- 2020
- Full Text
- View/download PDF
8. Transition of cancer in populations in India
- Author
-
Mathew, Aleyamma, George, Preethi Sara, K M, Jagathnath Krishna, Vasudevan, Durga, and James, Francis V.
- Published
- 2019
- Full Text
- View/download PDF
9. Comparison of imaging modalities for the accurate delineation of arteriovenous malformations (AVM) and evaluation of setup accuracy with reference to non-invasive LINAC-based stereotactic radiosurgery (SRS).
- Author
-
Sukumaran, Anju K., Raghavan, Rajeev K., Mathew, Beela S., Bhasi, Saju, Koshi, Sumod M., and K. M., Jagathnath Krishna
- Subjects
MAGNETIC resonance angiography ,DIGITAL subtraction angiography ,WILCOXON signed-rank test ,STEREOTACTIC radiosurgery ,ARTERIOVENOUS malformation - Abstract
Aims: To compare the accuracy of nidus delineation using magnetic resonance angiography (MRA) to digital subtraction angiography (DSA) and to evaluate setup accuracy of non-invasive frame SRS treatments. Settings and Design: A prospective observational study of 16 patients who underwent non-invasive frame LINAC-based SRS for brain AVMs. Materials and Methods: The nidus was separately delineated using DSA and MRA after co-registration onto CT simulation images and compared with respect to their volume and maximum diameters. During treatment, the setup errors observed in x-, y-, and z-directions were recorded. Statistical Analysis: Paired t-test (to compare volume and maximum diameter). Wilcoxon signed-rank test (for setup accuracy). Results: The mean volume of nidus contoured in MRA was 4.16 cc compared to 3.11 cc in DSA (P 0.297). The mean maximum diameters using MRA and DSA, respectively, in antro-posterior, cranio- caudal, and transverse diameters were 21.97 cc vs. 19.46 cc (P 0.2380), 6.59 cc vs. 9.63 cc (P 0.161), and 18.87 cc vs. 16.81 cc (P 0.178). But these modalities can potentially misinterpret the nidus volume, warranting caution for use of either modality alone. The mean translational shift observed in the x-, y-, and z-directions were 0.06 mm, 0.13 mm, and 0.13 mm, respectively, when couch was brought to neutral position after clockwise couch rotation and 0.07, 0, and 0, respectively, after counterclockwise couch rotation. Conclusion: This study could not demonstrate any statistically significant differences in nidus delineation between MRA and DSA. Setup accuracy achieved with non-invasive thermoplastic mask-based immobilization is within acceptable limits for SRS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Clinicopathological features and outcomes of adrenocortical carcinoma: A single institution experience
- Author
-
Lekha Madhavan Nair, K M Jagathnath Krishna, Aswin Kumar, Susan Mathews, John Joseph, and Francis Vadakkumparambil James
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Introduction: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with aggressive behavior. Most of our knowledge about this rare tumor is based on retrospective case series. This study aimed at analyzing the clinicopathological features and outcomes of patients treated at a tertiary cancer center in India. Patients and Methods: We retrospectively reviewed the data of patients with ACC registered from January 2006 to December 2015. Results: Thirty-seven patients were included in the study, 20 males and 17 females. Median age was 49 (18–78) years. Hormonal overproduction was noticed in 27% of patients. Median tumor size was 10 cm (2–22). Seventeen patients had metastatic disease and 20 patients were localised at diagnosis. Median follow-up was 22 months and median overall survival (OS) was 23.46 months. OS at 2 years and 5 years was 46.1% and 21%, respectively. The median disease-free survival (DFS) was 20 months. DFS at 2 years and 5 years was 45% and 24%, respectively. Age, sex, tumor size, hormonal overproduction, tumor laterality, and stage of the disease did not influence survival. However, advanced stage was associated with higher risk for recurrence. (P = 0.03). Conclusion: ACC is a rare endocrine malignancy with very poor survival rates. Rate of recurrence is high even after complete surgery. Systemic treatment options are limited. Newer agents are needed to improve outcome.
- Published
- 2019
- Full Text
- View/download PDF
11. LOSS TO FOLLOW-UP WEIGHTED ESTIMATION METHOD FOR SURVIVAL ANALYSIS
- Author
-
K. M. Jagathnath Krishna
- Subjects
General Medicine - Published
- 2023
- Full Text
- View/download PDF
12. Role of preoperative investigations in elderly patients undergoing oncosurgical procedures – A retrospective review audit
- Author
-
Bhagyalakshmi Ramesh, Viji S Pillai, Rachel C Koshy, and K M Jagathnath Krishna
- Subjects
Blood tests ,perioperative ,routine ,Anesthesiology ,RD78.3-87.3 ,Pharmacy and materia medica ,RS1-441 - Abstract
Background and Aims: The aim of the study was to evaluate the efficacy and usefulness of the current practice of various investigations and consultations being done during preanesthetic evaluation in patients undergoing oncosurgical procedures in our hospital. We also evaluated the delay caused due to these and its value in predicting postoperative complications. Material and Methods: The preanesthetic charts of 300 elderly patients >65 years of age were reviewed, and the incidence of abnormal investigations and number of consultations advised were noted. The incidence and predictive values of these were assessed. Results: More than half the number of patients had more than one comorbidity and were advised various consultations based on history, National Institute of Clinical and Health Excellence (NICE) guidelines, and institutional protocol. Multiple visits to preanesthetic clinic were required in patients who had abnormal thyroid tests or respiratory complaints which was the main reason for delay in scheduling surgery. However, despite multiple comorbidities not more than 12.7% of the blood tests ordered were found to be abnormal. Abnormal blood tests were not significantly associated with higher incidence of postoperative complications. Conclusion: Blood investigations do not predict postoperative complication rate and do not influence anesthetic management of elderly patients undergoing oncosurgical procedures but are rather influenced by surgical procedure and presence of comorbidities. Hence, preanesthetic clinic should assess patients based on other predictive tests rather than relying on blood investigations alone.
- Published
- 2018
- Full Text
- View/download PDF
13. Intraoperative pectoral nerve block (Pec) for breast cancer surgery: A randomized controlled trial
- Author
-
Mary Thomas, Frenny A Philip, Arun P Mathew, and K M Jagathnath Krishna
- Subjects
Breast neoplasm ,modified radical mastectomy ,nerve block ,postoperative pain ,ropivacaine ,Anesthesiology ,RD78.3-87.3 ,Pharmacy and materia medica ,RS1-441 - Abstract
Background and Aims: In centers with high turnover of breast surgeries, pectoral nerve block (Pec II) is time-consuming and requires ultrasound familiarity for administration. We decided to block the same nerves under vision after resection to evaluate postoperative analgesic effects. Material and Methods: Sixty patients scheduled for modified radical mastectomy were enrolled in this prospective, randomized, placebo-controlled, triple-blinded study. All patients received standardized general anesthesia. After surgical resection, infiltration of either ropivacaine (Group A) or saline (Group B) was given under vision at two points: 20 ml in the fascia over serratus anterior and 10 ml in the fascia between pectoralis major and minor at the level of the third rib. The primary outcomes measured were the time to first request for analgesia after extubation and total dose of analgesics needed, and secondary outcome included pain scores using the Numerical Rating Scale over 24 h. Analgesics used postoperatively were fentanyl citrate and paracetamol. We used Student's t-test to analyze quantity of analgesics needed, the nonparametric Mann–Whitney U-test for time to first request of analgesic, and Fisher's exact test for pain scores. Results: No patient in Group A required fentanyl. The mean time to first request for analgesia and mean dose of paracetamol required was 353.93 ± 135.03 min and 2.71 ± 0.462.71 g in Group A and 27.17 ± 18.08 min and 3.53 ± 1.074 g in Group B [P = 0.002]. Significantly more patients in Group A had mild pain scores compared to Group B. Conclusion: Pec II block with ropivacaine delivered under vision reduced analgesic requirement and pain scores significantly.
- Published
- 2018
- Full Text
- View/download PDF
14. Clinical Characteristics and Treatment Outcome of Waldenstrom Macroglobulinemia: Experience from a Tertiary Cancer Centre.
- Author
-
Narayanan, Geetha, Thambi, Sugeeth M., Gopan, Gayatri, Vasudevan, Jayasudha A., Nair, Sreejith G., Purushothaman, Prakash, Nair, Rekha A., and K. M., Jagathnath Krishna
- Subjects
CANCER treatment ,PARAPROTEINEMIA ,NON-Hodgkin's lymphoma ,CYTOPENIA ,IMMUNOGLOBULINS ,TREATMENT effectiveness ,TERTIARY care ,RETROSPECTIVE studies ,AGE distribution ,RITUXIMAB ,PLASMAPHERESIS ,DESCRIPTIVE statistics ,CANCER chemotherapy ,KAPLAN-Meier estimator ,LYMPHOPROLIFERATIVE disorders ,PROGRESSION-free survival ,DATA analysis software ,SPECIALTY hospitals ,OVERALL survival ,DISEASE progression ,SYMPTOMS - Abstract
Background: Waldenstroms macroglobulinemia (WM) or Lymphoplasmacytic lymphoma is a rare B cell lymphoproliferative malignancy characterized by serum monoclonal immunoglobulin M (IgM) protein and lymphoplasmacytic infiltration in the bone marrow. Patients usually present in their seventh decade with symptoms related to the infiltration of the marrow or the effects of monoclonal IgM in the blood. Objective: Was to study the clinical characteristics and treatment outcome of patients diagnosed with WM. Materials and methods: This is a retrospective analysis of 26 cases of WM treated at a tertiary cancer centre. Results: WM constituted 0.68% of our nonHodgkin's lymphoma. The median age at presentation was 67 years with a male to female ratio of 2:1. Four patients had lymphadenopathy, six had splenomegaly and four patients had evidence of hyper viscosity. All patients had IgM paraproteinemia, the M band was IgM-kappa in 19 patients and IgM-lambda in seven patients. All patients had a histopathological confirmation. According to IPSS-WM, 12 patients each were in the intermediate and high risk group and 2 in the low risk group. Among the 26 patients, 20 patients received upfront treatment and four patients were kept under observation. The indications for treatment were cytopenia in ten patients, constitutional symptoms in five, hyper viscosity in four and symptomatic lymphadenopathy in one patient. Sixteen patients received rituximab-based chemotherapy. Four patients with features with hyper viscosity underwent plasmapheresis. The three year progression free survival and overall survival were 69.4% and 78 % respectively. Conclusions: WM is a low grade B cell lymphoproliferative disorder having an indolent course and do not require treatment for prolonged period. Diagnosis is challenging due to lack of distinct diagnostic features. Rituximab containing regimens are the standard of care. Newer targeted treatment options may improve the outcome of this incurable disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer
- Author
-
Lekha Madhavan Nair, R Rejnish Kumar, Kainickal Cessal Thomachan, Malu Rafi, Preethi Sara George, K M. Jagathnath Krishna, and Kunnambath Ramadas
- Subjects
Chemoradiation ,cisplatin ,head and neck cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background: Concurrent chemoradiation with 3 weekly cisplatin (100 mg/m2) is the standard of care for locally advanced head and neck cancer. However, this regimen has been shown to be associated with lesser compliance and higher toxicities. Hence, there is a need to explore alternative concurrent cisplatin regimens. Objectives: The objective of this study was to compare the efficacy and toxicities of 3 weekly cisplatin (100 mg/m2) with weekly cisplatin (40 mg/m2) concurrently with radiation in patients with locally advanced head and neck cancer. Patients and Methods: This phase IIb trial randomized 56 patients with Stage III and IV squamous cell carcinoma of oropharynx, hypopharynx, and larynx to Arm A or Arm B. Arm A received cisplatin 100 mg/m2 3 weekly and Arm B received cisplatin 40 mg/m2 weekly concurrently with radiation. The primary end point was disease-free survival (DFS) and secondary end points were overall survival (OS) and acute toxicity. DFS and OS were estimated using Kaplan–Meier method, and log-rank test was used to assess the difference in these distributions with respect to treatment. Results: The 2-year DFS in Arm A and Arm B was 64.5% and 52.8%, respectively (P = 0.67). The OS at 2 years was 71% and 61.1% in Arm A and Arm B, respectively (P = 0.61). There were no significant differences in acute hematological, renal, or mucosal toxicities between the two arms. Conclusion: This study showed a nonsignificant improvement in DFS and OS in the 3 weekly cisplatin arm over the weekly arm with comparable toxicities. The trial is registered with Clinical Trial Registry of India (CTRI registration number: CTRI/2013/05/003703, URL-http://ctri.nic.in).
- Published
- 2017
- Full Text
- View/download PDF
16. Is Young Age an Independent Prognostic Factor in Carcinoma Breast? A Single-Institution Retrospective Comparative Study from South India
- Author
-
K. P. Abdulla, Paul Augustine, Neelima Radhakrishnan, Rexeena Bhargavan, K. M. Jagathnath Krishna, and Kurian Cherian
- Subjects
Oncology ,Surgery - Published
- 2022
- Full Text
- View/download PDF
17. Comparison of preoperative assessment tools in older patients undergoing cancer surgery: A prospective study
- Author
-
Frenny Ann, Philip, K M, Jagathnath Krishna, Rexeena V, Bhargavan, Paul, Augustine, and Shaji, Thomas
- Subjects
Male ,Fatigue Syndrome, Chronic ,Frailty ,Length of Stay ,Risk Assessment ,Postoperative Complications ,Oncology ,Risk Factors ,Neoplasms ,Humans ,Prospective Studies ,Geriatrics and Gerontology ,Geriatric Assessment ,Aged ,Retrospective Studies - Abstract
Surgery in older adults with cancer is complex due to multiple age related confounding factors. There are many scoring systems available for preoperative risk stratifications of older patients. Currently very few prospective studies comparing the various commonly used scales are available. This is the first study which compares the established preoperative risk assessment tools of Eastern Cooperative Oncology Group Performance Scale (ECOG) and American Society of Anaesthesiologists Physical Status Scale (ASA) with frailty scores of Modified Frailty Index (MFI) and Clinical Frailty Scale (CFS).This is a prospective observational study of older patients with cancer who underwent oncosurgery in a tertiary cancer centre during the one-year study period. Patients were scored on the CFS, MFI, ASA and ECOG scales. All patients were followed up for 30 days immediately following surgery and their post operative complications were documented. Univariate and multivariate analyses were done and a p value of ≤0.05 was considered statistically significant.Of the 820 patients studied, 15.6% had prolonged hospital stay, 9.1% had 30-day morbidity, 0.7% had readmission, and mortality was 1.1%. High-risk scores on the ASA and CFS were significantly associated with prolonged postoperative stay, readmission, morbidity, and mortality (p 0.05). High-risk scores on the ECOG was significantly associated with prolonged hospital stay (p = 0.027), 30-day morbidity (p = 0.003), and mortality (p = 0.001), but not with readmission. There was no significant association between MFI score and the postoperative variables studied (p 0.05). On multivariate analysis, morbidity was significantly associated only with male gender (p = 0.015), higher cancer stage (p = 0.005), higher ASA score (p = 0.029), and prolonged hospital stay (p = 0.001). Mortality was significantly associated only with emergency surgery (p = 0.012) and prolonged hospital stay (p = 0.004), and prolonged hospital stay was significantly associated with advanced cancer stage (p = 0.001) and emergency surgery (p = 0.02).In older patients undergoing cancer surgery, ASA and CFS are predictors of prolonged postoperative stay, morbidity, mortality, and readmission. A high-risk ECOG score is predictive of prolonged post operative stay, 30-day morbidity, and mortality, but not of readmission. Score on MFI is not a predictor of postoperative outcomes. Newer predictive tools which include cancer- specific factors are required for better management of these patients.
- Published
- 2022
- Full Text
- View/download PDF
18. A survey on the use of low flow anaesthesia and the choice of inhalational anaesthetic agents among anaesthesiologists of India
- Author
-
Rajasree Omanakutty Amma, Subha Ravindran, Rachel Cherian Koshy, and K M Jagathnath Krishna
- Subjects
Inhalational anaesthetic agents ,low flow anaesthesia ,survey ,Anesthesiology ,RD78.3-87.3 - Abstract
Background and Aims : With the availability of modern workstations and heightened awareness on the environmental effects of waste anaesthesia gases, anaesthesiologists worldwide are practicing low flow anaesthesia (LFA). Although LFA is being practiced in India, hard evidence on the current practice of the same from anaesthesiologists practicing in India is lacking and hence, we conducted this survey. Methods : A questionnaire containing 16 questions was distributed among a subgroup of anaesthesiologists who attended the 2014 National Conference of Indian Society of Anaesthesiologists. The filled-in questionnaires were computed and analysed with SPSS version 11. Results: The response rate to the survey was 82%. About 73% of the respondents practiced LFA routinely, with 65% having workstations. Most of the anaesthesiologists used fresh gas flows
- Published
- 2016
- Full Text
- View/download PDF
19. Determinants of Lymph Node Yield and Involvement in Resectable Colon Cancer: A Study of Anatomical, Pathological, and Fresh, Nonfixed Specimen Dissection
- Author
-
Sandeep Kumar Behera, null Chandramohan. K., Madhu Muralee, Renu Sukumaran, and K. M. Jagathnath Krishna
- Subjects
Surgery - Published
- 2023
- Full Text
- View/download PDF
20. Feasibility of Fertility-Sparing Surgery After Neoadjuvant Chemotherapy for Advanced Malignant Germ Cell Tumor of the Ovary
- Author
-
J. S. Anjana, S. Suchetha, P. Rema, J. Siva Ranjith, Dhanya Dinesh, Francis V. James, Aswin Kumar, and K. M. Jagathnath Krishna
- Subjects
Oncology ,Obstetrics and Gynecology - Published
- 2022
- Full Text
- View/download PDF
21. Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome
- Author
-
Gisha Rose Antony, Paul Augustine, Sulfath Thottungal Parambil, Ajeesh Babu Littleflower, Jayasree Kattoor, K. M. Jagathnath Krishna, and Lakshmi Subhadradevi
- Subjects
General Medicine ,General Biochemistry, Genetics and Molecular Biology - Abstract
Antitumor immune evasion is a hallmark for the development and progression of cancer. Tumor cells adopt various mechanisms to escape the host immune system recognition. One such mechanism is the over expression of programmed death ligand (PD-L1), a negative T cell regulatory molecule. Because PD-L1 overexpression causes resistance to chemotherapeutic response in many cancers, herein we explored the relationship between PD-L1 and multidrug resistance protein MDR1 in breast cancer. Immunohistochemical evaluation of PD-L1 and MDR1 proteins in 194 breast cancer tissue samples were carried out. The relationship between PD-L1 and MDR1 expression on cancer cells with clinicopathological factors and prognosis was investigated. IHC showed a significant correlation between PD-L1 and MDR1 expression on tumor cells. Increased PD-L1 expression was also associated with lymph node status and tumor grade of the patient. Our results also revealed that the expression of PD-L1 and MDR1 was higher in TNBC subtype compared to other breast cancer subtypes. Therefore, a better understanding of the molecular mechanism through which PD-1/PD-L1 pathway contribute to the chemoresistance might bring forth the prognostic significance of PD-L1 and selection of patients who may benefit from immunotherapy.
- Published
- 2022
- Full Text
- View/download PDF
22. Effect of BIS monitoring on sevoflurane consumption in patients undergoing breast cancer surgeries under general anesthesia—a prospective observational study
- Author
-
Sudha Padmam, Rachel Cherian Koshy, K M Jagathnath Krishna, Subha Ravindran, and Archana Nair
- Subjects
Mean arterial pressure ,Minimum alveolar concentration ,business.industry ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,Hemodynamics ,General Medicine ,lcsh:RC86-88.9 ,Sevoflurane consumption ,medicine.disease ,Institutional review board ,Sevoflurane ,lcsh:RD78.3-87.3 ,Breast cancer surgery ,Breast cancer ,Bispectral index ,lcsh:Anesthesiology ,Anesthesia ,Heart rate ,Medicine ,Observational study ,business ,medicine.drug - Abstract
Background The bispectoral index (BIS), a parameter derived from electroencephalogram, has been used to assess the depth of anesthesia. The objectives of this study were to evaluate the effect of BIS monitoring on sevoflurane consumption and recovery profile at the end of anesthesia. After obtaining Institutional Review Board approval and written informed consent, 25 American Society of Anesthesiologists (ASA) physical status classification 1 and 2 patients undergoing breast cancer surgeries who had BIS monitoring in addition to standard ASA monitoring (BIS GROUP) were compared against 25 controls (control group). In the control group, adequate depth of anesthesia was maintained using routine clinical parameters like heart rate (HR), mean arterial pressure (MAP), and minimum alveolar concentration (MAC) of sevoflurane, while in the BIS group, it was maintained by keeping the BIS score between 40 and 60 (mean 50). Data including demographics, sevoflurane consumption, hemodynamic variables, and recovery profile at the end of anesthesia was assessed in terms of time for eye opening (TEO), time for motor response (TMR), time for extubation (TE), and modified Aldrete scoring (MAS). Results The mean sevoflurane consumption was lower (P = 0.019) in the BIS group. TEO (P = 0.001), TMR (P = 0.0001), and TE (0.003) were shorter in the BIS group. Difference in MAS between the 2 groups was not statistically significant (P = 0.085). Conclusions BIS monitoring during anesthesia resulted in significant reduction in the sevoflurane consumption. Patients who had BIS monitoring awoke earlier and had better recovery profile at the end of anesthesia.
- Published
- 2021
23. Correlation of TIRADS and Bethesda Scoring Systems with Final Histopathology of Thyroid Nodules – An Institutional Experience
- Author
-
Shirish Patil, S. Renu, Deepak Janardhan, Sandeep Suresh, Shaji Thomas, Sanu P. Moideen, Ciju K. George, Deepa Mary Samuel, Nebu Abraham George, K. M. Jagathnath Krishna, and V. Jiji
- Subjects
Thyroid nodules ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Thyroid ,Bethesda system ,Thyroidectomy ,Nodule (medicine) ,Malignancy ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,medicine ,Surgery ,Histopathology ,Radiology ,medicine.symptom ,030223 otorhinolaryngology ,business ,Thyroid cancer - Abstract
Fine needle aspiration cytology (FNAC) reduces the number of unnecessary thyroid surgeries for patients with benign nodules and appropriately triages patients with thyroid cancer to appropriate treatment. This was a observational study done on cases presenting with clinical suspicion of thyroid malignancy which underwent ultrasonography followed by FNAC of thyroid nodule. Ultrasonographic characterization of nodules was based on Thyroid Imaging Reporting and Data System (TIRADS) and cytology reporting was based on Bethesda system. All recruited patients underwent thyroidectomy. Pre-operative cytology and ultrasonography features were compared with final histopathology report. In our study, Bethesda system of cytology reporting for thyroid nodules had a better sensitivity, specificity and diagnostic accuracy than TIRADS system of ultrasound reporting. Bethesda system in FNAC had a larger area under the ROC curve (0.91) as compared to ultrasound TIRADS (0.70). Malignancy rate of TIRADS 5 nodules was 97.1% with significant p value (0.022). 100% of Bethesda VI lesions were malignant according to final histopathology report. Ultrasound TIRADS could pre-operatively predict malignancy in 63.6% of indeterminate thyroid nodules which were malignant according to post-operative histopathology. The overall concordance of ultrasound TIRADS, Bethesda system and histopathology was 69.8%. Higher TIRADS and Bethesda scoring among thyroid nodules was associated with increased risk of malignancy. US TIRADS is a good predictor of malignancy in indeterminate thyroid nodules.
- Published
- 2021
- Full Text
- View/download PDF
24. Uterine Sarcoma: Retrospective Study From A Single institute
- Author
-
S. Suchetha, T. Vijayashanti, P. Rema, J. Sivaranjith, Aswin kumar, K. M. Jagathnath Krishna, and Francis. V. James
- Subjects
Obstetrics and Gynecology - Abstract
Uterine sarcomas are heterogeneous group of tumours comprising 1% of gynaecological malignancies. There is lack of concences on optimal treatment of uterine sarcomas. This is because of lack of randomised controlled trials due to rarity of these tumours. Surgical management without spill remains the standard primary treatment. Most of the times uterine sarcomas are diagnosed postoperatively from histopathology report of either myomectomy or hysterectomy. This retrospective study analysed the clinico pathological characteristics, prognostic factors, treatment details and survival outcome of different types of uterine sarcomas.This is a retrospective analysis of 59 patients of uterine sarcomas. All patients underwent surgery. Adjuvant chemotherapy or radiation treatment were given according to histopathological report and FIGO stage. Patients were followed up every three months for first two years and then every six months. Disease free survival (DFS) and Overall survival (OS) were calculated.The data were summarized using descriptive statistics as mean, percent and range. Survival probabilities were estimated using Kaplan-Meier method and the significance of difference between the survival curves were calculate using log-rank test.Uterine sarcomas are rare and aggressive tumours of uterus. Majority of these tumours present in early stage. Surgery remains the main treatment modality. Role of adjuvant radiation treatment remains controversial. Tumour stage is the most important prognostic factor.
- Published
- 2021
25. Immunological Effects of Laparoscopic Versus Open Rectal Cancer Surgery
- Author
-
T. R. Santhosh Kumar, Chandramohan Krishnan Nair, Bharat Veerabhadran, Sanjeev Kulkarni, Madhu Muralee, Arun Peter Mathew, K M Jagathnath Krishna, and Mira Sudam Waugh
- Subjects
medicine.medical_specialty ,Plastic surgery ,Cardiothoracic surgery ,business.industry ,Pediatric surgery ,medicine ,Rectal cancer surgery ,Surgery ,Neurosurgery ,business ,Cardiac surgery - Published
- 2020
- Full Text
- View/download PDF
26. Does addition of postmastectomy radiotherapy improve outcome of patients with pT1-2, N0 triple negative breast cancer as compared to breast conservation therapy?
- Author
-
Rajeev Kavalakara Raghavan, K M Jagathnath Krishna, Shabna Ibrahim, and Beela Sarah Mathew
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Lymphovascular invasion ,modified radical mastectomy ,medicine.medical_treatment ,Triple Negative Breast Neoplasms ,Modified Radical Mastectomy ,lcsh:RC254-282 ,Disease-Free Survival ,03 medical and health sciences ,Mastectomy, Modified Radical ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Breast conservation therapy ,Mastectomy ,Triple-negative breast cancer ,Neoplasm Staging ,Retrospective Studies ,business.industry ,Significant difference ,General Medicine ,Middle Aged ,Postmastectomy radiation ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Radiation therapy ,030104 developmental biology ,Lymphatic Metastasis ,030220 oncology & carcinogenesis ,triple-negative breast cancer ,Lymph Node Excision ,Female ,Radiotherapy, Adjuvant ,Neoplasm Recurrence, Local ,business - Abstract
Background: Triple-negative breast cancers (TNBCs) form a heterogeneous group of cancers typically exhibiting an aggressive behavior resulting in increased risk of locoregional relapse (LRR) and distant metastases. The effect of radiotherapy on LRR risk and overall survival (OS) in women treated with mastectomy alone for early-stage TNBC remains unclear. Aim: The aim of this study is to compare the locoregional recurrence rate, disease-free survival (DFS), and OS following breast conservation therapy (BCT) or modified radical mastectomy (MRM) alone in women with stage I and IIA TNBC and to assess the impact of tumor and treatment-related factors. Materials and Methods: Patients with early-stage (pT1-2, N0) TNBC-treated between January 1, 2010, and December 31, 2011, were identified from the hospital-based registry records. The mean age was 48 years. Forty-nine patients underwent BCT, and 121 underwent MRM. The majority of the patients in both groups had T2 and grade 3 disease. None of the patients had margin positive status after surgery. Five patients had lymphovascular invasion (LVI). Results: At a median follow-up of 50 months (range: 4–83 months), there was no locoregional recurrence (LRR) in either arm. Eight patients relapsed, six developed distant metastases, and one patient each had a new primary in the contralateral breast and ovary. Two patients died of disseminated cancer, one each in the BCT and MRM groups. The five-year DFS was 95.8% and 91.1% for the BCT group and MRM group, respectively, (P = 0.83). The corresponding 5-year OS was 98% and 97.5% (P = 0.527). There was no statistically significant difference in outcome based on age, grade, LVI, or margin status between both groups. Conclusion: This retrospective analysis identified no statistically significant difference in outcome regarding LRR, DFS, or OS in patients treated without adjuvant radiation for women with pT1-T2N0 TNBC who underwent MRM in comparison to BCT.
- Published
- 2019
27. Clinicopathological features and outcomes of adrenocortical carcinoma: A single institution experience
- Author
-
K M Jagathnath Krishna, Aswin Kumar, Francis V James, Susan Mathews, Lekha Nair, and John Joseph
- Subjects
medicine.medical_specialty ,business.industry ,Urology ,030232 urology & nephrology ,Cancer ,Disease ,lcsh:Diseases of the genitourinary system. Urology ,lcsh:RC870-923 ,medicine.disease ,Malignancy ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,Medicine ,Clinicopathological features ,Adrenocortical carcinoma ,Endocrine system ,Original Article ,Stage (cooking) ,business ,Hormone - Abstract
Introduction: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with aggressive behavior. Most of our knowledge about this rare tumor is based on retrospective case series. This study aimed at analyzing the clinicopathological features and outcomes of patients treated at a tertiary cancer center in India. Patients and Methods: We retrospectively reviewed the data of patients with ACC registered from January 2006 to December 2015. Results: Thirty-seven patients were included in the study, 20 males and 17 females. Median age was 49 (18–78) years. Hormonal overproduction was noticed in 27% of patients. Median tumor size was 10 cm (2–22). Seventeen patients had metastatic disease and 20 patients were localised at diagnosis. Median follow-up was 22 months and median overall survival (OS) was 23.46 months. OS at 2 years and 5 years was 46.1% and 21%, respectively. The median disease-free survival (DFS) was 20 months. DFS at 2 years and 5 years was 45% and 24%, respectively. Age, sex, tumor size, hormonal overproduction, tumor laterality, and stage of the disease did not influence survival. However, advanced stage was associated with higher risk for recurrence. (P = 0.03). Conclusion: ACC is a rare endocrine malignancy with very poor survival rates. Rate of recurrence is high even after complete surgery. Systemic treatment options are limited. Newer agents are needed to improve outcome.
- Published
- 2019
28. A randomized controlled trial to study the effect of intratracheal and intravenous lignocaine on airway and hemodynamic response during emergence and extubation following general anesthesia
- Author
-
Divya V, Gladston, Sudha, Padmam, Rajasree Omanakutty, Amma, Rachel Cherian, Koshy, K M Jagathnath, Krishna, Jayasree, Vijayan, Nimmy, George, and Praveen, Rajendran
- Subjects
Randomized controlled trial ,law ,business.industry ,Haemodynamic response ,Anesthesia ,Medicine ,General anaesthesia ,business ,Airway ,General Economics, Econometrics and Finance ,law.invention - Abstract
Intratracheal (IT) and intravenous (IV) lignocaine suppress airway reflex and hemodynamic response during extubation, but studies regarding this are sparse. The primary aim was to compare the effect of IT and IV lignocaine on attenuation of airway reflex to endotracheal extubation and the secondary aim was to compare the hemodynamic responses to extubation, using lignocaine by the two different routes.Seventy-five female patients with comparable age, body mass index, and American Society of Anesthesiologists Physical Status undergoing carcinoma breast surgery were randomized into three groups. Group A received 2% lignocaine 3 mg/kg intratracheally 5 min and Group B received 2% lignocaine 1.5 mg/kg intravenously 3 min before extubation. Group C was control group. The airway and hemodynamic responses were noted in terms of episodes of cough during emergence and extubation. Categorical variables assessed using Fisher's exact test and continuous variables assessed using one-way analysis of variance.Cough suppression was present in Groups A and B, with better results observed with IT than with IV lignocaine. In the control group, Grade III cough reflex was present predominantly. There was a statistically significant difference (p0.001) in blood pressure and heart rate between Group A versus Group C and in Group B versus Group C, but not between Group A and Group B.IT lignocaine administered before extubation significantly attenuates post-extubation cough reflex than IV lignocaine. Both IT and IV lignocaine can effectively attenuate the airway and hemodynamic response to extubation.
- Published
- 2021
29. Stage migration and treatment outcome in carcinoma tongue – A comparison of seventh and eighth AJCC pathological staging systems.
- Author
-
George, Rebecca, Prakasan, Aparna, K. R., Anila, K. M., Jagathnath Krishna, Iype, Elizabeth Mathew, K., Jayasree, and Ramadas, Kunnambath
- Subjects
TUMOR classification ,TONGUE cancer ,GLOSSECTOMY ,TREATMENT effectiveness ,AKAIKE information criterion ,SQUAMOUS cell carcinoma ,REGRESSION analysis - Abstract
Background: The eighth edition of the American Joint Committee on Cancer (AJCC) for oral cancer has incorporated additional pathological features like depth of invasion (DOI) and extranodal extension (ENE) into T and N staging. The incorporation of these two factors will impact the staging and, hence, the treatment decisions. The aim of the study was to clinically validate the new staging system in predicting the outcome in patients treated for carcinoma oral tongue. The study also examined the correlation of pathological risk factors with survival. Methods: We studied 70 patients with squamous cell carcinoma of the oral tongue who underwent primary surgical treatment at a tertiary care center in the year 2012. All these patients were restaged pathologically according to the new AJCC eighth staging system. The 5‑year overall survival (OS) and disease‑free survival (DFS) were calculated using the Kaplan–Meier method. Akaike information criterion and concordance index were calculated between both staging systems to identify a better predictive model. Log‑rank test and univariate Cox regression analysis were conducted to find out the significance of different pathological factors on outcome. Results: Incorporation of DOI and ENE resulted in 47.2% and 12.8% stage migration, respectively. DOI less than 5 mm was associated with a 5‑year OS and DFS of 100% and 92.9%, respectively, compared to 88.7% and 85.1%, respectively, when the DOI was more than 5 mm. Presence of lymph node involvement, ENE, and perineural invasion (PNI) were associated with inferior survival. The eighth edition had lower Akaike information criterion and improved concordance index values compared with the seventh edition. Conclusion: The eighth edition of AJCC allows better risk stratification. Restaging of cases based on the eighth edition AJCC staging manual resulted in significant upstaging with difference in survival. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Risk factors and prevalence of cervical squamous intraepithelial lesions among women in south India: A community-based cross-sectional study
- Author
-
M C, Kalavathy, Aleyamma, Mathew, K M, Jagathnath Krishna, V N, Saritha, and K, Sujathan
- Subjects
Vaginal Smears ,Cross-Sectional Studies ,Risk Factors ,Squamous Intraepithelial Lesions ,Papillomavirus Infections ,Prevalence ,Humans ,India ,Uterine Cervical Neoplasms ,Female ,Uterine Cervical Dysplasia ,Papanicolaou Test - Abstract
"Cervical cancer in India accounts for one-fifth of the global burden. Well-defined precancerous stages help early detection of the disease. Apart from human papillomavirus, the risk factors include age, education, occupation, early age at marriage and first delivery, abortions, and multiple sexual partners. Prevalence and risk factors for cervical squamous intraepithelial lesions (SIL) among women by Pap smear screening in south India were analyzed through a cross-sectional study."Women from rural and urban area were motivated by local accredited social health activists to attend pre-fixed Pap smear clinics in government hospitals. Pap smears collected in these clinics were taken to the Regional Cancer Centre, Thiruvananthapuram, processed, and cytology reports were prepared. Multiple logistic regression analysis was used to identify risk factors for SIL and high-grade SIL (HSIL)."The number of SIL was 67 out of 10,580 and HSIL was 39. Having higher education (Odds Ratio, OR:0.05(95% Confidence Interval, CI: 0.01-0.2), being married but living single (OR : 5.3, 95%CI:2.4-11.5), Having2 abortions (OR:21, 95% CI:4.5-24), having younger age at delivery (OR : 0.1, 95% CI:0.01-0.3) and having unhealthy cervix (OR: 16.4, 95% CI:6.2-42.7) were the factors found to be the associated risk factors in multiple regression analysis."Pap smear screening can be focused on women with risk factors such as low education, married but living single, having2 abortions, younger age at delivery, and unhealthy cervix on per speculum examination.
- Published
- 2021
31. Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India
- Author
-
Priyakumari Thankamony, C.S. Guruprasad, Rekha A Nair, Kaduveettil Gopinathan Gopakumar, V.R. Prasanth, Priya Mary Jacob, Shwetha Seetharam, Binitha Rajeswari, Manjusha Nair, and K M Jagathnath Krishna
- Subjects
Male ,medicine.medical_specialty ,Myeloid ,Adolescent ,Prednisolone ,medicine.medical_treatment ,India ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Asparaginase ,Humans ,Child ,Retrospective Studies ,Chemotherapy ,Mixed phenotype acute leukemia ,business.industry ,Daunorubicin ,Myeloid leukemia ,Cancer ,Retrospective cohort study ,Hematology ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,medicine.disease ,Survival Analysis ,Leukemia ,Treatment Outcome ,medicine.anatomical_structure ,Oncology ,Vincristine ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Prednisone ,Female ,business ,030215 immunology ,medicine.drug - Abstract
There is limited data regarding pediatric mixed phenotype acute leukemia (MPAL) and there is no global consensus on its management yet. In this retrospective study, we analyzed the outcomes of children diagnosed with MPAL at our institute. This study included children ≤ 14 years with MPAL who presented to a tertiary cancer center in India from January 1st 2009 to December 31st 2015. Over a seven-year period, 1390 patients with leukemia presented to our institute of which 22 patients (1.5%) had MPAL. Sixteen patients (72.7%) had B/myeloid leukemia, while 4 (18.1%) and 2 (9%) patients had T/myeloid and B/T leukemia respectively. Twenty-one patients were treated with a modified BFM ALL 95 protocol. 76.1% (n = 16) of patients had a good prednisolone response (GPR) on day 8 and end-of-induction (EOI) marrow was in remission in 90.5% (n = 19). A poor prednisolone response (PPR) on day 8 correlated with an inferior relapse-free survival (25% vs 79.5%, P=.025). The 4-year event-free survival (EFS) and overall survival (OS) for the entire group was 60.8% and 64.9% respectively while the EFS for patients who had a GPR and remission at the EOI (n = 15) was 80% as compared to 16.7% in patients with PPR or induction failure. Lymphoid directed chemotherapy is seen to have good survival outcomes in pediatric MPAL. However, a PPR on day 8 or a positive EOI marrow may be an indication for more aggressive treatment.
- Published
- 2021
- Full Text
- View/download PDF
32. A randomized controlled trial to study the effect of intratracheal and intravenous lignocaine on airway and hemodynamic response during emergence and extubation following general anesthesia.
- Author
-
Gladston, Divya V., Padmam, Sudha, Amma, Rajasree Omanakutty, Koshy, Rachel Cherian, K. M., Jagathnath Krishna, Vijayan, Jayasree, George, Nimmy, and Rajendran, Praveen
- Subjects
RANDOMIZED controlled trials ,LIDOCAINE ,HEMODYNAMICS ,EXTUBATION ,ANESTHESIA - Abstract
OBJECTIVE: Intratracheal (IT) and intravenous (IV) lignocaine suppress airway reflex and hemodynamic response during extubation, but studies regarding this are sparse. The primary aim was to compare the effect of IT and IV lignocaine on attenuation of airway reflex to endotracheal extubation and the secondary aim was to compare the hemodynamic responses to extubation, using lignocaine by the two different routes. METHODS: Seventy-five female patients with comparable age, body mass index, and American Society of Anesthesiologists Physical Status undergoing carcinoma breast surgery were randomized into three groups. Group A received 2% lignocaine 3 mg/kg intratracheally 5 min and Group B received 2% lignocaine 1.5 mg/kg intravenously 3 min before extubation. Group C was control group. The airway and hemodynamic responses were noted in terms of episodes of cough during emergence and extubation. Categorical variables assessed using Fisher’s exact test and continuous variables assessed using one-way analysis of variance. RESULTS: Cough suppression was present in Groups A and B, with better results observed with IT than with IV lignocaine. In the control group, Grade III cough reflex was present predominantly. There was a statistically significant difference (p<0.001) in blood pressure and heart rate between Group A versus Group C and in Group B versus Group C, but not between Group A and Group B. CONCLUSION: IT lignocaine administered before extubation significantly attenuates post-extubation cough reflex than IV lignocaine. Both IT and IV lignocaine can effectively attenuate the airway and hemodynamic response to extubation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Prognostic factors and outcomes of nonseminomatous germ cell tumours of testis—experience from a tertiary cancer centre in India
- Author
-
Francis V James, John Joseph, Aswin Kumar, Susan Mathews, Lekha Nair, and K M Jagathnath Krishna
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,germ cell tumours ,testis ,survival ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,nonseminoma ,Cancer centre ,Cox proportional hazards regression ,medicine ,Chemotherapy ,Visceral metastasis ,Proportional hazards model ,business.industry ,Incidence (epidemiology) ,Cancer ,medicine.disease ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Clinical Study ,030211 gastroenterology & hepatology ,business ,Germ cell - Abstract
Germ cell tumour of the testis is the most common cancer in young men in the western world. India has the lowest incidence globally, and hence Indian data are sparse. We report the outcomes of patients with nonseminomatous germ cell tumours of testis treated at a tertiary cancer centre in South India over a period of 10 years. Patients with a histopathological diagnosis of nonseminomatous germ cell tumours of the testis from 1 January 2006 to 31 December 2016 were included in the study. Patient demographics, tumour characteristics and treatment details were retrieved from case records. Kaplan-Meier method was used to estimate progression-free survival (PFS) and overall survival (OS). Cox regression model was used to analyse the prognostic factors. One hundred and nineteen patients with nonseminomatous germ cell tumours of the testis were included in the study. The median follow-up was 81 months. The estimated 4-year OS and progression-free survival were 87.1% and 84.5%, respectively. The four-year OS for good, intermediate and poor-risk groups was 93.6%, 87.5% and 52.6%, respectively. The PFS at 4 years was 91.4%, 87.8% and 47.4% for good, intermediate and poor-risk groups, respectively. The presence of nonpulmonary visceral metastasis and biochemical response after chemotherapy were significant predictors for OS and PFS in multivariate cox proportional hazards regression. The survival figures are comparable to the rest of the world except in the poor prognostic risk group. The inferior survival noticed in this group of patients may be due to the lack of good salvage procedures. High-dose chemotherapy with stem-cell support may be considered more often for this group of patients.
- Published
- 2020
34. Outcome of Definitive Treatments in Primary Vaginal Cancer Patients: An Institutional Review
- Author
-
John Joseph, P. Krishnapriya, K M Jagathnath Krishna, Susan Mathews, Francis V James, and Aswin Kumar
- Subjects
Vaginal cancer ,medicine.medical_specialty ,030219 obstetrics & reproductive medicine ,Hysterectomy ,business.industry ,medicine.medical_treatment ,Brachytherapy ,Obstetrics and Gynecology ,medicine.disease ,Surgery ,Radiation therapy ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Oncology ,Surgical oncology ,030220 oncology & carcinogenesis ,medicine ,Vagina ,External beam radiotherapy ,Stage (cooking) ,business - Abstract
To review the treatment outcome in primary vaginal cancer patients who underwent definitive treatment at our institution. A total of 43 patients with histologically proven primary vaginal cancer, who were treated between January 2005 to December 2015, were identified. All were treated with definitive radiotherapy with or without concurrent chemotherapy. Radiotherapy was delivered as a combination of external beam radiotherapy and brachytherapy to a minimum dose of 60 Gy. Four patients were FIGO stage I, 13 were stage II, 23 stage III patients and three patients were stage IVA. The median age was 60 years (range 42–76). The median follow-up was 29 months with a range of 3 to 70 months. The different variables looked into like the histology, lower third of vagina involvement and prior hysterectomy did not show any difference in survival. Addition of concurrent chemotherapy was the only factor which showed a trend towards better survival with a p value of 0.09. Even in the subset of patients with prior hysterectomy, those who received definitive treatment with concurrent chemo-radiotherapy had a better two-year progression-free survival than those who received radiotherapy alone (57.4% Vs 10.5%). A combination of EBRT and brachytherapy with concurrent chemotherapy is a reasonable option in the management of primary vaginal cancer. Further optimization of the dose and techniques of radiotherapy are warranted.
- Published
- 2020
- Full Text
- View/download PDF
35. Evaluation of Factors Affecting Margin Positivity and Persistent Disease After Leep for Cervical Intraepithelial Neoplasia
- Author
-
Aleyamma Mathew, Anila Tresa Alukal, S. Suchetha, J. Sivaranjith, K M Jagathnath Krishna, Dhanya Dinesh, P. Rema, and Thara Somanathan
- Subjects
Colposcopy ,Cervical cancer ,medicine.medical_specialty ,030219 obstetrics & reproductive medicine ,Hysterectomy ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Obstetrics and Gynecology ,Cervical intraepithelial neoplasia ,medicine.disease ,Lesion ,03 medical and health sciences ,Persistent Disease ,0302 clinical medicine ,Margin (machine learning) ,medicine ,Histopathology ,Original Article ,030212 general & internal medicine ,Radiology ,medicine.symptom ,business - Abstract
BACKGROUND: Cervical intraepithelial neoplasia (CIN) is the precursor lesion of cervical cancer. Untreated high-grade CIN significantly increases the risk of developing invasive cancer. Conization is the main treatment. Loop electrosurgical excision procedure (LEEP) is the most common conization method used. The study aims to assess the risk factors associated with positive margin and persistent disease after LEEP for CIN. MATERIALS AND METHODS: A total of 156 patients who underwent LEEP during 2011–2018 included in the study. We analyzed the socio-demographic characteristics, colposcopy details, dimensions of LEEP specimen (thickness, length, volume) and histopathology (margin positivity, grade). Persistent disease was histologically confirmed by repeat LEEP and hysterectomy. RESULTS: Margin positivity was noted in 33.3% (52) patients. Residual disease was noted in 26.2% (41) of the patients who had undergone a repeat LEEP or hysterectomy. There was a significant association between margin positivity and Swede score of 5 or more, a high-grade lesion on IFCPC score, inner margin involvement, LEEP done in a single pass. The cutoff for margin positivity was length of 0.513 cm and thickness of 0.35 cm. A significant association between residual disease and margin positivity, postmenopausal status, Swede score of 5 or more, high-grade lesion on IFCPC score, inner margin involvement was observed. The chance of residual disease was less if the cone specimen had minimum length of 0.775 cm and minimum thickness of 0.65 cm. CONCLUSION: When in doubt regarding the margins, it is always better to perform multiple passes for lesions with a high Swede score with an initial smear of HSIL. Postmenopausal women with inner margin positivity have a high chance of residual disease and should be either kept on close follow-up or consider a repeat procedure.
- Published
- 2020
36. Prevalence and Risk Factors for Metabolic Syndrome Among Childhood Acute Lymphoblastic Leukemia Survivors: Experience From South India
- Author
-
Garima Nirmal, Guruprasad Chellapam Sojamani, Priyakumari Thankamony, Manjusha Nair, Binitha Rajeswari, K M Jagathnath Krishna, and Prasanth Varikkattu Rajendran
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Population ,India ,Overweight ,Coronary artery disease ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Cancer Survivors ,Risk Factors ,medicine ,Prevalence ,Humans ,Obesity ,Prospective Studies ,education ,Child ,Childhood Acute Lymphoblastic Leukemia ,Metabolic Syndrome ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,Hematology ,Odds ratio ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,medicine.disease ,Prognosis ,Oncology ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Female ,Metabolic syndrome ,medicine.symptom ,business ,030215 immunology ,Follow-Up Studies - Abstract
BACKGROUND AND OBJECTIVES Improved survival of childhood acute lymphoblastic leukemia (ALL) has diverted attention to the long-term consequences of the treatment; metabolic abnormalities being one of the most important issues. METHODS Children diagnosed with ALL at age 14 years and younger at Regional Cancer Centre in South India who completed treatment and who were on follow-up for >2 years were enrolled in the study between April 1, 2018 and March 31, 2019. They were prospectively evaluated for the presence of metabolic syndrome (MS) and associated risk factors. RESULTS AND DISCUSSION A total of 277 survivors of pediatric ALL were recruited during the study period. MS was present in 8.3% (n=23) and 6% (n=13) survivors by National Cholesterol Education Programme Adult Treatment Panel III (NCEPATP III) and International Diabetes Federation (IDF) criteria, respectively. The prevalence of overweight and obesity in the survivors was 9% and 13%. The prevalence of increased waist circumference, low high-density lipoprotein cholesterol, elevated triglycerides, elevated fasting glucose, and increased blood pressure were 10.5%, 28.9%, 24.9%, 2.5%, and 9%, respectively. Overweight/obese survivors were at an increased risk for developing MS (odds ratio=17.66; 95% confidence interval=6.2-50.16, P=0.001). Survivors who received cranial radiotherapy were at an elevated risk for having low high-density lipoprotein cholesterol (P=0.001). CONCLUSIONS In our study, the prevalence of MS was higher in childhood ALL survivors, as compared with the general population. The study points to the need for regular screening of pediatric ALL survivors for early detection of MS, along with lifestyle modification in those with metabolic abnormalities, to curb the growing incidence of coronary artery disease.
- Published
- 2020
37. Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer
- Author
-
Kainickal Cessal Thomachan, R. Rejnish Kumar, Kunnambath Ramadas, Preethi Sara George, Lekha Nair, Malu Rafi, and K M Jagathnath Krishna
- Subjects
0301 basic medicine ,Larynx ,Oncology ,Cancer Research ,medicine.medical_specialty ,cisplatin ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Clinical endpoint ,Stage (cooking) ,Cisplatin ,business.industry ,Head and neck cancer ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Acute toxicity ,Clinical trial ,Regimen ,030104 developmental biology ,medicine.anatomical_structure ,Chemoradiation ,ORIGINAL ARTICLE: Head and Neck Cancer ,030220 oncology & carcinogenesis ,head and neck cancer ,business ,medicine.drug - Abstract
Background: Concurrent chemoradiation with 3 weekly cisplatin (100 mg/m2) is the standard of care for locally advanced head and neck cancer. However, this regimen has been shown to be associated with lesser compliance and higher toxicities. Hence, there is a need to explore alternative concurrent cisplatin regimens. Objectives: The objective of this study was to compare the efficacy and toxicities of 3 weekly cisplatin (100 mg/m2) with weekly cisplatin (40 mg/m2) concurrently with radiation in patients with locally advanced head and neck cancer. Patients and Methods: This phase IIb trial randomized 56 patients with Stage III and IV squamous cell carcinoma of oropharynx, hypopharynx, and larynx to Arm A or Arm B. Arm A received cisplatin 100 mg/m2 3 weekly and Arm B received cisplatin 40 mg/m2 weekly concurrently with radiation. The primary end point was disease-free survival (DFS) and secondary end points were overall survival (OS) and acute toxicity. DFS and OS were estimated using Kaplan–Meier method, and log-rank test was used to assess the difference in these distributions with respect to treatment. Results: The 2-year DFS in Arm A and Arm B was 64.5% and 52.8%, respectively (P = 0.67). The OS at 2 years was 71% and 61.1% in Arm A and Arm B, respectively (P = 0.61). There were no significant differences in acute hematological, renal, or mucosal toxicities between the two arms. Conclusion: This study showed a nonsignificant improvement in DFS and OS in the 3 weekly cisplatin arm over the weekly arm with comparable toxicities. The trial is registered with Clinical Trial Registry of India (CTRI registration number: CTRI/2013/05/003703, URL-http://ctri.nic.in).
- Published
- 2017
- Full Text
- View/download PDF
38. Higher incidence of syndrome of inappropriate antidiuretic hormone secretion during induction chemotherapy of acute lymphoblastic leukemia in indian children
- Author
-
Shwetha Seetharam, K M Jagathnath Krishna, Priyakumari Thankamony, and Kaduveettil Gopinathan Gopakumar
- Subjects
0301 basic medicine ,Male ,Vincristine ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Drug-Related Side Effects and Adverse Reactions ,medicine.medical_treatment ,India ,Inappropriate ADH Syndrome ,Tertiary Care Centers ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,Humans ,Prospective Studies ,Adverse effect ,Prospective cohort study ,Child ,Chemotherapy ,business.industry ,Incidence (epidemiology) ,Incidence ,Induction chemotherapy ,Induction Chemotherapy ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,medicine.disease ,Antineoplastic Agents, Phytogenic ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Child, Preschool ,Syndrome of inappropriate antidiuretic hormone secretion ,Female ,business ,Hyponatremia ,medicine.drug - Abstract
BACKGROUND: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a well-known adverse effect of vincristine (VCR). Literature suggests that Asians are predisposed to develop SIADH following VCR administration. However, data regarding the occurrence of SIADH in children with malignancy are limited. This study aims to analyze the incidence, clinical picture, risk factors, management, and outcome of SIADH during induction chemotherapy for pediatric acute lymphoblastic leukemia (ALL). MATERIALS AND METHODS: A prospective study was conducted among the 166 newly diagnosed pediatric ALL patients who were treated at a tertiary cancer center in India between January 2015 and December 2015. Patients who developed hyponatremia during induction chemotherapy were further investigated for SIADH. RESULTS: The incidence of SIADH was 10.8% (n = 18) with a mean sodium level of 125 mEq/L (114–129 mEq/L). In the preceding 2 weeks, 72% of episodes were associated with the administration of two (n = 6) or three (n = 7) doses of VCR. One child presented with seizures. All the patients were managed with fluid restriction and only two patients required sodium correction with 3% saline. Girls older than 10 years of age showed a marginally significant correlation to develop SIADH (P-value = 0.059). CONCLUSION: We report a higher incidence of SIADH (10.8%) in Indian children, compared to that described in the literature, during induction chemotherapy for ALL. Regular monitoring of sodium levels during this period of chemotherapy is hence essential for the timely diagnosis and appropriate management of SIADH, which in turn will avert complications, including neurological symptoms secondary to SIADH.
- Published
- 2019
39. Role of preoperative investigations in elderly patients undergoing oncosurgical procedures - A retrospective review audit
- Author
-
Bhagyalakshmi Ramesh, K M Jagathnath Krishna, Viji S. Pillai, and Rachel Cherian Koshy
- Subjects
medicine.medical_specialty ,lcsh:RS1-441 ,Nice ,Audit ,lcsh:RD78.3-87.3 ,lcsh:Pharmacy and materia medica ,Medicine ,Pharmacology (medical) ,In patient ,perioperative ,General Pharmacology, Toxicology and Pharmaceutics ,computer.programming_language ,Blood tests ,Retrospective review ,business.industry ,Incidence (epidemiology) ,Postoperative complication ,Perioperative ,medicine.disease ,Comorbidity ,routine ,Anesthesiology and Pain Medicine ,lcsh:Anesthesiology ,Emergency medicine ,Original Article ,business ,computer - Abstract
Background and Aims: The aim of the study was to evaluate the efficacy and usefulness of the current practice of various investigations and consultations being done during preanesthetic evaluation in patients undergoing oncosurgical procedures in our hospital. We also evaluated the delay caused due to these and its value in predicting postoperative complications. Material and Methods: The preanesthetic charts of 300 elderly patients >65 years of age were reviewed, and the incidence of abnormal investigations and number of consultations advised were noted. The incidence and predictive values of these were assessed. Results: More than half the number of patients had more than one comorbidity and were advised various consultations based on history, National Institute of Clinical and Health Excellence (NICE) guidelines, and institutional protocol. Multiple visits to preanesthetic clinic were required in patients who had abnormal thyroid tests or respiratory complaints which was the main reason for delay in scheduling surgery. However, despite multiple comorbidities not more than 12.7% of the blood tests ordered were found to be abnormal. Abnormal blood tests were not significantly associated with higher incidence of postoperative complications. Conclusion: Blood investigations do not predict postoperative complication rate and do not influence anesthetic management of elderly patients undergoing oncosurgical procedures but are rather influenced by surgical procedure and presence of comorbidities. Hence, preanesthetic clinic should assess patients based on other predictive tests rather than relying on blood investigations alone.
- Published
- 2019
40. Long-term hypocalcemia prediction post thyroidectomy
- Author
-
P.G. Balagopal, Nebu Abraham George, Sandeep Suresh, Deepak Janardhan, and K. M. Jagathnath Krishna
- Subjects
Completion thyroidectomy ,Total thyroidectomy ,endocrine system ,business.industry ,medicine.medical_treatment ,Thyroidectomy ,Sequela ,medicine.disease ,Hypoparathyroidism ,Weighted score ,Anesthesia ,Statistical significance ,medicine ,General Earth and Planetary Sciences ,Cutoff point ,business ,hormones, hormone substitutes, and hormone antagonists ,General Environmental Science - Abstract
Introduction: Hypocalcemia is a common sequela of total thyroidectomy and is usually transient (30%), only a few develop permanent hypoparathyroidism. Till date, no effective risk stratification score to predict hypocalcemia is available that can predict postoperative hypocalcemia. Materials and Methods: This was a prospective observational study including all patients who underwent total or completion thyroidectomy with initial parathormone (PTH) within the normal range in our institution during a 1 year period. Postoperative 6th h PTH fall was noted in all patients and cutoff point for the prediction of long-term hypocalcemia (LTHP) was determined using a paired t-test. Results: Postoperatively, calcium supplementation was initiated in 52% of patients. In 7.6% of patients who had a fall in PTH to more than 80% of preoperative value, calcium supplementation could not be tapered even after 3 months postoperatively. About 66% of patients
- Published
- 2021
- Full Text
- View/download PDF
41. An Extension of the Freund's Bivariate Distribution to Model Load-Sharing Systems
- Author
-
G. Asha, K M Jagathnath Krishna, and Debasis Kundu
- Subjects
021103 operations research ,Exponential distribution ,Applied Mathematics ,0211 other engineering and technologies ,02 engineering and technology ,Extension (predicate logic) ,Bivariate analysis ,01 natural sciences ,General Business, Management and Accounting ,Exponential function ,010104 statistics & probability ,symbols.namesake ,Joint probability distribution ,Component (UML) ,Statistics ,symbols ,0101 mathematics ,Fisher information ,Random variable ,Mathematics - Abstract
SYNOPTIC ABSTRACTSeveral authors have considered the analysis of load-sharing parallel systems. The main characteoristics of such a two-component system is that after the failure of one component, the surviving component has to shoulder extra load, and hence, it is more likely to fail earlier than would be expected under the original model. In other cases, the failure of one component may release extra resources to the other component, thus delaying the system failure. Freund introduced a bivariate extension of the exponential distribution, which is applicable to two-component load-sharing systems. It is based on the assumption that the lifetime distributions of the components are exponential random variables before and after the change. In this article, we introduce a new class of bivariate distribution using the proportional hazard model. It is observed that the bivariate model proposed by Freund is a particular case of our model. We study different properties of the proposed model. Different statistica...
- Published
- 2016
- Full Text
- View/download PDF
42. A survey on the use of low flow anaesthesia and the choice of inhalational anaesthetic agents among anaesthesiologists of India
- Author
-
K M Jagathnath Krishna, Rajasree Omanakutty Amma, Rachel Cherian Koshy, and Subha Ravindran
- Subjects
Inhalational anaesthetic agents ,medicine.drug_class ,010501 environmental sciences ,01 natural sciences ,lcsh:RD78.3-87.3 ,03 medical and health sciences ,0302 clinical medicine ,030202 anesthesiology ,Low flow anaesthesia ,medicine ,low flow anaesthesia ,survey ,0105 earth and related environmental sciences ,Response rate (survey) ,Volatile agent ,business.industry ,medicine.disease ,Inhalational anaesthetic ,Anesthesiology and Pain Medicine ,lcsh:Anesthesiology ,Current practice ,Anesthesia ,Bispectral index ,Original Article ,Medical emergency ,business - Abstract
Background and Aims : With the availability of modern workstations and heightened awareness on the environmental effects of waste anaesthesia gases, anaesthesiologists worldwide are practicing low flow anaesthesia (LFA). Although LFA is being practiced in India, hard evidence on the current practice of the same from anaesthesiologists practicing in India is lacking and hence, we conducted this survey. Methods : A questionnaire containing 16 questions was distributed among a subgroup of anaesthesiologists who attended the 2014 National Conference of Indian Society of Anaesthesiologists. The filled-in questionnaires were computed and analysed with SPSS version 11. Results: The response rate to the survey was 82%. About 73% of the respondents practiced LFA routinely, with 65% having workstations. Most of the anaesthesiologists used fresh gas flows
- Published
- 2016
43. 208P Prognostic factors and outcomes of non-seminomatous germ cell tumours of testis: Experience from a tertiary cancer centre in India
- Author
-
Lekha Nair, John Joseph, Aswin Kumar, K M Jagathnath Krishna, Susan Mathews, and Francis V James
- Subjects
Oncology ,medicine.medical_specialty ,medicine.anatomical_structure ,business.industry ,Internal medicine ,Cancer centre ,medicine ,Hematology ,business ,Germ cell - Published
- 2020
- Full Text
- View/download PDF
44. Intraoperative pectoral nerve block (Pec) for breast cancer surgery: A randomized controlled trial
- Author
-
Frenny Ann Philip, Arun Peter Mathew, K M Jagathnath Krishna, and Mary Thomas
- Subjects
medicine.medical_specialty ,modified radical mastectomy ,medicine.medical_treatment ,Analgesic ,lcsh:RS1-441 ,Modified Radical Mastectomy ,Fentanyl ,law.invention ,nerve block ,lcsh:RD78.3-87.3 ,lcsh:Pharmacy and materia medica ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Randomized controlled trial ,030202 anesthesiology ,law ,medicine ,Pharmacology (medical) ,General Pharmacology, Toxicology and Pharmaceutics ,ropivacaine ,Ropivacaine ,business.industry ,Breast neoplasm ,medicine.disease ,Surgery ,Exact test ,Anesthesiology and Pain Medicine ,lcsh:Anesthesiology ,Nerve block ,Original Article ,business ,postoperative pain ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Background and Aims: In centers with high turnover of breast surgeries, pectoral nerve block (Pec II) is time-consuming and requires ultrasound familiarity for administration. We decided to block the same nerves under vision after resection to evaluate postoperative analgesic effects. Material and Methods: Sixty patients scheduled for modified radical mastectomy were enrolled in this prospective, randomized, placebo-controlled, triple-blinded study. All patients received standardized general anesthesia. After surgical resection, infiltration of either ropivacaine (Group A) or saline (Group B) was given under vision at two points: 20 ml in the fascia over serratus anterior and 10 ml in the fascia between pectoralis major and minor at the level of the third rib. The primary outcomes measured were the time to first request for analgesia after extubation and total dose of analgesics needed, and secondary outcome included pain scores using the Numerical Rating Scale over 24 h. Analgesics used postoperatively were fentanyl citrate and paracetamol. We used Student's t-test to analyze quantity of analgesics needed, the nonparametric Mann–Whitney U-test for time to first request of analgesic, and Fisher's exact test for pain scores. Results: No patient in Group A required fentanyl. The mean time to first request for analgesia and mean dose of paracetamol required was 353.93 ± 135.03 min and 2.71 ± 0.462.71 g in Group A and 27.17 ± 18.08 min and 3.53 ± 1.074 g in Group B [P = 0.002]. Significantly more patients in Group A had mild pain scores compared to Group B. Conclusion: Pec II block with ropivacaine delivered under vision reduced analgesic requirement and pain scores significantly.
- Published
- 2018
45. Characteristics of Foot Dimensions of Children with Cerebral Palsy and Standardizing Orthosis Size - Through an Anthropometric Pilot Study
- Author
-
G. Gautham, Md. Sadiq, B. N. Das, D. Suresh Kumar, and K. M. Jagathnath Krishna
- Subjects
medicine.medical_specialty ,business.industry ,Anthropology ,medicine ,Physical therapy ,sense organs ,Impaired gait ,Anthropometry ,skin and connective tissue diseases ,medicine.disease ,business ,Foot (unit) ,Cerebral palsy - Abstract
Children with Cerebral Palsy have foot debilitation resulting in change in foot dimension and impaired gait. To overcome this problem customised orthoses are often prescribed. This increases the le...
- Published
- 2015
- Full Text
- View/download PDF
46. Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study
- Author
-
K M Jagathnath Krishna, Than Singh Tomar, Rema Prabhakaran Nair, Iqbal M. Ahmed, Aleyamma Mathew, and Suchetha Sambasivan
- Subjects
Adult ,Validation study ,medicine.medical_specialty ,Neoplasm, Residual ,Population ,03 medical and health sciences ,0302 clinical medicine ,Cytoreduction Surgical Procedures ,Ovarian carcinoma ,Carcinoma ,medicine ,Humans ,In patient ,education ,Laparoscopy ,Aged ,Neoplasm Staging ,Ovarian Neoplasms ,education.field_of_study ,030219 obstetrics & reproductive medicine ,medicine.diagnostic_test ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,Debulking ,Surgery ,Treatment Outcome ,Oncology ,030220 oncology & carcinogenesis ,Female ,business - Abstract
The objective of this study was to evaluate the safety and efficacy of laparoscopy in detecting inoperable disease in patients undergoing interval cytoreduction (ICR) for advanced ovarian carcinoma (AOC). The primary outcome measured was the performance of laparoscopy-based predictive index value (PIV) score developed by Fagotti et al. The secondary outcomes measured were performance of individual parameters included in PIV score and optimal cytoreduction (OCR) rates in our population.This is a single-arm, prospective validation trial. Patients undergoing ICR for AOC in our institution were evaluated prospectively with laparoscopy before planned attempt at debulking surgery. Seven laparoscopic parameters included in laparoscopic PIV score were evaluated. Laparoscopic findings were compared with the final outcomes of definitive surgery. OCR was defined as residual disease1 cm. The efficiency of the individual laparoscopy score was analyzed using receiver operating characteristic (ROC) curves.A total of 73 patients planned for ICR for AEOC were included in the study. Laparoscopic PIV score could successfully predict inoperability in 12 (16.4% of total study population) out of 14 inoperable patients in the total population and thus could avoid 85% of unsuccessful surgeries at a PIV score cutoff of ≥8. Performance of individual parameters included in PIV score was also evaluated. Two parameters out of seven, that is, mesenteric retraction and stomach infiltration had poor performance on ROC curve. Modified PIV score was calculated for each patient after excluding these two parameters. Modified PIV score had similar performance as Fagotti's PIV score at cutoff ≥6 (P = 0.728, for difference in area under the curve). No staging laparoscopy-related serious adverse events were noted in any of the patients.Laparoscopy is a safe, effective, and accurate method for predicting inoperability in patients undergoing ICR for AEOC.
- Published
- 2017
- Full Text
- View/download PDF
47. Treatment outcomes and prognostic factors of esthesioneuroblastoma -- a retrospective study from South India.
- Author
-
Nair, Lekha Madhavan, Mathew, John Mohan, Rafi, Malu, Thommachan, Kainickal Cessal, K. M., Jagathnath Krishna, Varghese, Bipin T., and Ravikumar, Rejnish
- Subjects
- *
PROGNOSIS , *TREATMENT effectiveness , *NEURAL crest , *OVERALL survival , *REGRESSION analysis , *SMELL disorders - Abstract
Esthesioneuroblastoma (ENB) or olfactory neuroblastoma is a rare malignant neoplasm arising from the neural crest cells of the olfactory epithelium. The optimum treatment for this rare disease is still unclear. Most of the available literature on this rare head and neck tumour is limited to small retrospective series and single institutional reports. We conducted a retrospective study to investigate the clinical profile, treatment outcomes and prognostic factors of patients with ENB treated at a tertiary cancer centre in south India. Patients with a histopathological diagnosis of ENB treated from 2000 to 2019 were included. Patient demographics, tumour characteristics, stage, treatment details and outcome data were identified from medical records. Overall survival (OS) and disease-free survival (DFS) were estimated using the Kaplan-Meier method and the log-rank test was used for comparison. The prognostic factors were identified using Cox regression analysis. Forty-two patients underwent treatment for ENB from 2000 to 2019. Twenty-six patients underwent surgery. Twelve patients received radical radiotherapy (RT) while 24 patients underwent adjuvant radiation. After a median follow-up of 71 months, the estimated OS and DFS at 4 years were 64.4% and 54%, respectively. The estimated 4-year OS for modified Kadish A, B, C and D stages was 75.0%, 90.9%, 56.4% and 0%, respectively. Modified Kadish stage, nodal involvement, orbital invasion, intracranial extension, surgery, RT treatment and use of chemotherapy were significant predictors of OS and DFS in univariate Cox regression analysis. Orbital invasion and RT treatment were significant predictors of DFS in the multivariate analysis as well. However, only RT treatment came out to be a significant predictor for OS in multivariate Cox regression analysis. Surgery is the mainstay of treatment. Adjuvant RT may improve local control and survival in advanced cases. Advanced modified Kadish stage, lymph node involvement and orbital invasion are associated with poor outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. Assessment of spatial variation in lung cancer incidence and air pollutants: spatial regression modeling approach.
- Author
-
S S, Mathew A, K M JK, P RN, Sankar A, T R V, and George PS
- Abstract
A notable finding is that Kerala's capital Thiruvananthapuram has shown an increasing trend in lung cancer (LC) incidence. Long-term exposure to air pollution is a significant environmental risk factor for LC. This study investigated the spatial association between LC and exposure to air pollutants in Thiruvananthapuram, using Spatial Lag Model (SLM), Spatial Error Model (SEM), and Geographically Weighted Regression (GWR). The results showed that overall LC incidence rate was 111 per 10
5 males (age >60 years), whereas spatial distribution map revealed that 48% of the area had an incidence rate greater than 150. The results revealed a significant association between PM2.5 and LC. SLM was identified as the best model that predicted 62% variation in LC. GWR model improved model performance and made better local predictions in the southeastern parts of the study area. This study explores the effectiveness of spatial regression techniques for dealing spatial effects and pinpointing high-risk areas.- Published
- 2024
- Full Text
- View/download PDF
49. Impact of COVID-19 on Disease Progression and Postoperative Complications in Patients with Head and Neck Cancer.
- Author
-
Nadarajan AR, George NA, Thomas S, Varghese BT, Iype EM, and K M JK
- Abstract
The COVID-19 pandemic has created a remarkable challenge for the healthcare system. The delayed presentation, diagnosis, and treatment of head and neck cancer during the COVID-19 pandemic is expected to adversely affect outcomes. COVIDSurg collaborative group in 2020 concluded surgery ≥ 4 weeks after a positive COVID-19 swab result was associated with a lower risk of postoperative mortality. The aim of this study is to assess the disease progression due to COVID-19 infection in patients with head and neck cancer planned for surgery and to analyze the postoperative complications in head and neck cancer patients who underwent surgery after COVID-19 infection. This is an ambispective observational study and included patients with head and neck cancer who recovered from COVID-19 infection and underwent surgery from June 2020 to May 2022. There were a total of 1849 patients with head and neck cancer operated in the mentioned study period during COVID-19 pandemic. One hundred fifty-nine patients had documented COVID-19 infection. One hundred two patients had oral cavity carcinoma (64%), and 38 patients had thyroid carcinoma (23.8%). Early disease was noted in 49 patients (30.8%) and locally advanced disease in 108 patients (67.9%). Mean duration of delay in surgery was 4 weeks. Disease progression was noted in 27 patients (17%) out of which 15 patients were inoperable. Thirty-seven out of 159 patients (23%) had postoperative complications, and it included 2 mortality. There was increased trend noted in pulmonary complications and hemorrhage when compared to pre-COVID-19 era. Due to COVID-19 pandemic, delayed elective head and neck cancer surgery has resulted in higher rates of inoperability. COVID-19 has been associated with increased postoperative pulmonary complications and hemorrhage., Competing Interests: Competing InterestsThe authors declare no competing interests., (© The Author(s), under exclusive licence to Indian Association of Surgical Oncology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)
- Published
- 2023
- Full Text
- View/download PDF
50. Cancer Incidence and Mortality: District Cancer Registry, Trivandrum, South India
- Author
-
Mathew A, Sara George P, M C K, G P, K M JK, and Sebastian P
- Abstract
Background: Cancer is emerging as a major cause of morbidity and mortality in low and middle-income countries. Cancer registry figures help for planning and delivery of health services. This paper provided the first results of cancer incidence and mortality [Crude (CR) and age-standardized (ASR)] rates (world-standard population) of Trivandrum district, South India and compared with other registries under the network of National Cancer Registry Programme (NCRP), Government of India. Materials and Methods: Trivandrum district cancer registry encompasses a population of 3.3 million, compiles data from nearly 75 sources (hospitals and diagnostic laboratories) and included under the NCRP in 2012. During 2012-2014, registry recorded 15,649 incident cases and 5667 deaths. Proportion of microscopic diagnosis was 85% and ‘Death certificate only’ was 8%. Results: Total cancer incidence (CRs) rates were 161 and 154 (ASR: 142.2 and 126) and mortality rates were 66 and 49 (ASR: 54 and 37) per 105 males and females respectively. Common cancers in males were lung (ASR:19), oral cavity (ASR:15), colo-rectum (ASR:11.2), prostate (ASR:10.2) and lymphoma (ASR:7) and in females, breast (ASR:36), thyroid (ASR:13.4), cervix-uteri (ASR:7.3), ovary (ASR:7) and colo-rectum (ASR:7). Nationally, the highest CRs for breast, prostate, colo-rectum, corpus-uteri and urinary bladder cancers and low incidence of cervix-uteri cancer were observed in Trivandrum. Conclusion: Cancer incidence (CR) in Trivandrum was the highest in both genders in India (except Aizwal). This is mainly due to the highest lifeexpectancy in Kerala. Also, an epidemiologic transition in cancer pattern is taking place and is changing to more similar to “western” jurisdictions., (Creative Commons Attribution License)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.